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Abstract:  
We developed and simulated a systems model of the population of military personnel and 
veterans affected by post-traumatic stress disorder (PTSD). Simulation results fit the historical 
data on PTSD prevalence in 2000-2014, and forecast the trends for the next decade under 
several scenarios of US involvement in future wars. Using the model, we tested the effects on 
PTSD prevalence and healthcare costs of four PTSD policies aimed at improving: 1) resiliency, 2) 
screening, 3) treatment, and 4) a combination of the three. Results showed that in a postwar 
period, there is no silver bullet for overcoming the problems of PTSD, and screening and 
treatment policies must be revolutionized to have any noticeable effect. One critical 
characteristic of this system is the long time that it takes, about 40 years, to vanquish the 
psychiatric consequences of a war. In a very optimistic scenario, estimated PTSD prevalence 
among veterans in 2025 will be at least 10%.  
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1. Introduction 
Wars have considerable invisible costs, a major one being mental illness, for military personnel, 
veterans, and their family members [1]. Post-traumatic stress disorder (PTSD) stands out as a 
major life-threatening mental illness. It is the result of experiencing trauma, and the illness 
often shows symptoms long after events. Currently, more than two percent of the US 
population (about 7.7 million people) are known to suffer from PTSD, and eight to nine percent 
of the US population report experiencing lifelong PTSD [2]. The cascading effects of PTSD and 
comorbidity with other illnesses threaten patients’ lives. People who have PTSD are about three 
times more likely to use marijuana, and at least six times more likely to use addictive drugs such 
as cocaine [3]. PTSD patients are also three times more at risk of suicide [4]. In addition to 
patients, many others are indirectly affected by PTSD, including family members, friends, 
community members, colleagues, and employers. 
Despite the importance of problems related to PTSD, little is known about effective policies for 
prevention or early diagnosis. There are three major barriers to developing effective policies. 
First, PTSD is a multi-organizational challenge [5]. In simple terms, patients’ family members, 
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employers, colleagues, communities, and neighborhoods are often involved in cases of PTSD. At 
the macro level, larger entities such as the military, the healthcare system, the Department of 
Veterans Affairs (VA), and elected government officials are concerned and involved with the 
problems of PTSD. These stakeholders have different preferences and incentives. Focusing on 
one organization or a specific stage of patients’ lives can result in shifting the burden to another 
organization rather than addressing the main roots of the problem. Most past policy studies of 
PTSD focus on one sector, usually a single organization such as the military. Second, similar to 
other dynamically complex problems, there are long delays between causes and effects. There 
is currently a huge number of unknown PTSD patients—those who have not yet shown any 
signs of the illness. Symptoms of PTSD are sometimes delayed for a decade [6], making current 
policies inadequate or ineffective. Finally, there are huge uncertainties about the prevalence of 
PTSD, the performance of screening procedures, and the accuracy of diagnosis [7]. Screening 
procedures are usually self-reported surveys, and the subjective answers can suffer from errors 
or be intentionally manipulated to avoid the stigma of the illness or malingering [5, 8].  
Therefore, the importance and complexity of PTSD raise critical questions: What are the trends 
in the population of PTSD patients among military personnel and veterans in the postwar era? 
What policies can help mitigate the effects of PTSD? What are the healthcare cost implications 
of potential policies? Furthermore, the complexity of a dynamic problem such as PTSD, which 
includes potential delays between causes and effects, is beyond the understanding of the 
human brain [9, 10]. From this complexity emerges the use of systems science and simulation-
based policy analysis [11], particularly system dynamics modeling [12, 13]. While systems 
models of different health-related problems have been developed [14-16], this study is the first 
to develop a system dynamics simulation model of PTSD, a model that includes both military 
personnel and veterans in a ‘system of systems’. This is a novel aspect in our model since many 
policies implemented at the military level will potentially influence (and may have side effects 
on) veterans and the Department of Veterans Affairs. Calibrating the model to historical data, 
we estimated the future trends in the population with PTSD under various scenarios of US 
involvement in future wars. We further tested various policies for resource allocation, 
treatment and screening. 
2. Study data and methods 
We used time series datasets (2000-2014) from the Department of Defense, the Institute of 
Medicine, the Department of Veterans Affairs, and other sources (see Appendix 1) to set the 
baseline scenario and fit the model to the data. We also extensively used the literature as a 
source of model parameters (see Appendix 2). Our model presents the flow of people from 
recruitment into the military, from military service to the post-military stage, and from the 
post-military stage to death. The basic structure of the model is illustrated in Figure 1. The 
model contains two major sections (large dashed boxes): military and post-military. Each 
section has three stages (shown in rectangles) connected by ten potential pathways (arrows).  
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Figure 1: A simplified representation of the PTSD model of “Military/Post-military” system 
 
Figure 1 represents different paths in this system. First, people enter the military through 
recruitment (path 1). The model divides people in the military into three categories: healthy, ill-
undiagnosed, and ill-diagnosed. The majority of the new hires are PTSD-free and are in the 
healthy military category (path 1a). However, there is a chance of hiring people with a history of 
PTSD (path 1b). Healthy people move to ill-undiagnosed if they develop PTSD as a result of 
trauma (path 2). In this stage, they do not show any symptoms of PTSD. People move from ill-
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undiagnosed to ill-diagnosed when they exhibit symptoms and are diagnosed (path 3). The 
population of ill-diagnosed may separate or get discharged, moving to post-military (path 7), or 
receive effective treatment and move back to the healthy sub-population (path 4). Given that 
the symptoms of PTSD are usually delayed, the ill-undiagnosed population might not show any 
symptoms while in the military; the problems may arise after their separation from the military 
(path 6). In each of these stages, a very small proportion of service personnel die due to PTSD-
related or unrelated events; this is included in the model, but for the sake of simplicity it is not 
shown in Figure 1.   
People leave the military and become veterans through three paths: healthy separation (path 
5), separation with unknown illness (path 6), and separation/discharge with known illness (path 
7). Similar to the military section, we divide the population in the post-military into healthy, ill-
undiagnosed, and ill-diagnosed. The ill-undiagnosed veterans move to the ill-diagnosed sub-
population when they are diagnosed with PTSD (path 8). Effective treatment in the post-
military stage can move these ill individuals back into the healthy population (path 9). Finally, 
veterans leave the post-military stage when they die (path 10).  
The model follows the described structure. For each state variable (box), the value is 
mathematically represented by the integration of inflow(s) minus outflow(s), following system 
dynamics methodology [9]. Detailed model formulations for each stage are fully documented in 
Appendix 3, and follow a set of minimum reporting requirements [17]. The model is calibrated 
to the data and unknown parameters are estimated—see Appendix 4 for more discussion and 
estimation results. Various sensitivity analyses showed that simulation results are robust for 
considerable changes in parameters and data errors (Appendix 5).  
3. Study Results 
While the developed model is complex and encompasses various details about military 
personnel, it is still a simplification of reality; as such, it should be carefully tested and validated 
for the purposes of the modeling project. To build confidence in the usefulness of the model, 
we conducted various tests, such as tests of structure and behavior validity [18], unit 
consistency, and equation robustness in extreme conditions [12]. Moreover, in the formulation 
of equations, we tested them against different input values to ensure that the logic portrayed 
in the data was represented [19]. The model was carefully calibrated to data using the partial 
model calibration method [20], which gives relatively more robust parameter estimates than 
other methods [21]  [20]. And finally, behavior reproduction tests were conducted to evaluate 
the ability of the model to reproduce key behaviors observed in datasets (such as the trends of 
PTSD patients in the military, combat-related PTSD diagnosis rate in the military, PTSD patients 
in VA facilities, PTSD diagnosis rate in VA facilities, pre-2000 veterans with PTSD, Iraq and 
Afghanistan veterans with PTSD, PTSD costs in the military, and PTSD costs in VA facilities), 
which helped build further confidence in the model’s usefulness [22]. For more information on 
model validation and sensitivity analysis of the estimated parameters, see Appendix 5.  
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3.1. Base Run  
We consider three scenarios for future engagements in wars:  
• Scenario 1 (S1): Minimum deployment to intense/combat zones (1% of military 
personnel); this is the current Obama administration policy for post-2015;  
• Scenario 2 (S2): 2% deployment to intense/combat zones.    
• Scenario 3 (S3): 5% deployment to intense/combat zones.   
 
As a baseline for comparison, during 
2001-2014, on average, 6.6% of US 
military personnel were deployed 
annually to combat zones, a rate that 
reached a maximum of 10.8% in 2008.  
Figure 2 presents the base run 
simulations of the model for diagnosis 
rate in the military through the historical 
period starting in 2000 and then in the 
future through 2025. In addition to 
simulation outputs, historical data (2000-
2014) is also presented in Figure 2. Figure 
2 shows how closely the simulated 
results are fit with the historical data. 
Figure 2-a depicts the diagnosis rate in 
the military, which is annual new cases. 
As the figure shows, the number of new 
cases of PTSD has been declining since 
2013, which is mainly due to decreasing 
the number of troops in Iraq and 
Afghanistan in recent years. The future 
trend, however, is very sensitive to US 
involvement in future wars, represented 
by the three scenarios (S1-S3). As 
depicted in Figure 2-b, the population of 
people with PTSD in the military 
significantly declines over time, reaching 
28,000 in S1 and 36,000 in S2 in 2025. In 
S3, PTSD prevalence in the military 
increases greatly; diagnosed cases are 
estimated to be 58,000. Figure 2-c 
presents the PTSD population among 
veterans. Overall, the population of patients among veterans declines very slowly in 
 
(a) Diagnosis rate in military [new cases per year]  
 
(b) Diagnosed cases in military 
 
(c) Diagnosed cases in veterans  
Figure 2: Base run simulations 
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comparison to the military, since people remain in the post-military stage for a long time 
(basically until death). Despite decreasing deployments, new cases will be diagnosed every year 
among veterans, since there is a delay between developing the illness and showing symptoms, 
revealing the long-lasting effects of wars. Under S3, which assumes more US troop involvement 
in future wars (equal to half of the involvement in Iraq and Afghanistan during 2000-2013), the 
population of patients among veterans stays relatively constant at around 600,000 over the 
next decade. Overall, Figure 2, shows relatively slow changes in the PTSD population, even 
when the number of new cases significantly declines, and also shows the sensitivity of the 
results to the scenarios of US involvement in future wars.    
We also conducted two additional 
analyses with the model. First, we 
estimated direct annual costs of PTSD 
for the military and the VA healthcare 
systems (based on the dollar value in 
2012), see Figure 3-a. Cost estimation 
was performed based on the 
assumption of constant costs per PTSD 
patient in the military and the VA over 
the next decade. Average cost per 
patient was extracted from the 
Institute of Medicine’s report [7]. In S1, 
estimated healthcare costs for the 
military and VA were $125 million and 
$2.95 billion, respectively. In S2, these 
estimates rose to $164 million for the 
military and $3.15 billion for the VA. In 
S3, the estimates reached $264 million 
for the military and $3.63 billion for 
the VA.  
Second, we ran a counter-factual 
analysis, from a steady state condition, 
presented in Figure 3-b. The simulation 
runs discussed above captured various 
factors that occur during the period 
2000-2014. In this counterfactual, we 
used the estimated parameters from the model, but isolated all exogenous variables. The 
purpose of this simulation was to analyze the inertia in the system and measure how long it 
takes to vanquish the effects of a short 5-year war with 10% troop deployment (around the 
maximum deployment in Iraq). The results, presented in Figure 3-b, show the long delay 
required to vanquish the psychological effects of a war. Controlling for treatment, screening, 
 
(a) PTSD health costs in 2025, based on the dollar value in 2012 
 
(b) A counterfactual analysis to measure the effects of a short-
term war (between years zero and five) on PTSD prevalence in 
the military and among veterans. 
Figure 3: Cost projection and inertia analysis in the 
system of military and post-military systems 
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and training policies, Figure 3-b shows that it takes about 40-45 years for the veteran 
population to become PTSD-free. This represents the long-lasting effects of a war. Furthermore, 
Figure 3-b shows that the peak for the PTSD population among veterans emerges about six 
years after the war ends, due to various delays in the system, and the PTSD population is much 
higher among the veterans than in the military.   
 
3.2. Policy Analysis 
We analyzed all combinations of the three scenarios (S1-S3, discussed in Section  3.1) and five 
policy interventions using our model. For policy interventions, we had one control group (base 
run) and four policies. Similar to most other health interventions, these four policies focus on 
improving diagnosis, treatment effectiveness, and prevention. In Policy 1, improving diagnosis, 
the focus was on screening. We formulated this policy by doubling the screening sensitivity (the 
ratio of true positive to total positive cases). In Policy 2, the focus was on improving treatment, 
and we tested the effects of doubling the chance of effective treatment while PTSD patients are 
in the military. In Policy 3, we tested the effects of improvement in PTSD prevention. This policy 
represented effective training programs that might improve the resilience of military personnel 
to PTSD, by decreasing the likelihood of getting PTSD after trauma. We formulated a condition 
where resiliency to a trauma was doubled, meaning that the chance of developing PTSD after 
experiencing trauma was halved. In each of the policies, a single model input was changed; 
however, in Policy 4, we tested the combination of Policy 1, Policy 2, and Policy 3.  
We used two major policy measures: PTSD prevalence and PTSD healthcare costs. Table 1 
presents these policy measures for 2025. In Table 1-a, PTSD prevalence is reported. For each 
sector (military, veterans, and total system), 15 combinations of the three scenarios (S1-S3) and 
five policy interventions are presented. For example, in the military, under S1 (little 
involvement in future wars), PTSD prevalence was estimated to be 7% in the base run. If 
policies 1 or 2 were implemented, PTSD prevalence remained around 7%. However, with Policy 
3, prevalence decreased to 5%, and with Policy 4 it further decreased to 4%. Table 1 is colored 
to emphasize the magnitude of the numbers and provide comparisons across all conditions 
(darker colors present larger numbers). A similar table is offered for healthcare costs in the 
military and the VA (Table 1-b).  
Based on Table 1-a, it is notable that Policy 1 and Policy 2 had almost no effect compared to the 
corresponding values in the base run. The main reason is that with the current effectiveness of 
treatments (argued to be low), more screening only leads to finding more people who are PTSD 
positive. A sole focus on treatment does not help either, because most patients are late-
diagnosed. The effects of Policy 3 (prevention) and Policy 4 (combination) were considerable 
for the military, especially under S3. It is important to note that the effects of Policy 3 and 
Policy 4 were still limited to the small population of military personnel with PTSD, and the VA 
will be still facing a large number of PTSD patients (between 10% and 11%).  
8 
 
Based on Table 1-b, Policy 1 increases healthcare costs in the military by 2025. In all conditions 
presented in Table 1-b, the numbers were higher than the corresponding base run simulation. 
Under this policy, since more people are screened, more PTSD positives are diagnosed. The 
policy results in finding more patients. However, without advancements in treatment, screening 
improvement only increases the demand for care. Thus, policy 1 can make us worse off in cost-
related measures (PTSD costs in the military and the VA) and has almost no effect on PTSD 
prevalence. In terms of costs, the best policy seems to be a focus on treatment. This policy 
mainly discharges already diagnosed patients at a faster pace. Similar to the previous measure, 
the effects are limited to the military, and in the VA, costs change marginally and are still on the 
order of $3 billion. However, this policy also has a limited effect on PTSD prevalence, as many 
patients remained undiagnosed while in the military. Overall, Policy 3, which focuses on 
prevention by increasing the resiliency to PTSD, seems to be more effective in terms of 
decreasing both PTSD prevalence and costs. 
 
Table 1: Simulation results for PTSD prevalence and healthcare costs in 2025 for the military, the VA, and the 
total military-VA system under different scenarios (S1-S3) times interventions (Policy 1 – Policy 4). 
(a): PTSD prevalence in 2025 (%) 
  Military Veterans Total System 
  S1 S2 S3 S1 S2 S3 S1 S2 S3 
Base Run 7 11 21 10 10 11 9 10 12 
Policy 1 (Screening) 7 10 20 9 10 11 9 10 12 
Policy 2 (Treatment) 7 10 20 10 10 11 9 10 12 
Policy 3 (Prevention) 5 9 13 9 10 10 9 10 11 
Policy 4 (Mixed) 4 6 12 9 10 10 9 9 10 
 
(b): PTSD healthcare costs in 2025 (in billions, based on the dollar value in 2012) 
  Military Veterans Total System 
  S1 S2 S3 S1 S2 S3 S1 S2 S3 
Base Run 0.13 0.16 0.26 2.95 3.15 3.63 3.08 3.31 3.89 
Policy 1 (Screening) 0.18 0.25 0.41 3.11 3.33 3.90 3.29 3.58 4.31 
Policy 2 (Treatment) 0.09 0.12 0.20 2.83 3.01 3.48 2.92 3.13 3.68 
Policy 3 (Prevention) 0.11 0.14 0.19 2.88 3.06 3.33 2.99 3.20 3.52 
Policy 4 (Mixed) 0.10 0.13 0.21 2.86 3.00 3.39 2.96 3.13 3.60 
Note: For each sector (military, veterans, and total system), 15 combinations of the three scenarios (S1-
S3) and five policy interventions are presented. One way to read the table is to compare the effects of 
policies in a scenario (e.g., S1). For example, in military, under S1 (little involvement in future wars), PTSD 
healthcare costs are estimated to be $0.13B in the base run. For policies 1 through 4, the PTSD 
healthcare costs are estimated to be $0.18B, $0.09B, $0.11B, and $0.10B, respectively. Another way to 
read the table is to compare different scenarios over a policy.  
 
Overall, the changes in the numbers presented in Table 1 are much larger (under any policy), 
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when we move from S1 to S3, than the policy interventions themselves. While these policies 
can influence the PTSD prevalence and costs in the military, for the total system (military and 
VA), the effects of all policies are marginal. Comparing the policies, Policy 4, which is a 
combination of screening, treatment, and prevention, has a potential effect in mitigating PTSD.  
4. Conclusions 
We developed a systems model of the population of military personnel and veterans affected 
by post-traumatic stress disorder (PTSD) and compared the results with the actual data for 
2000-2014. Then the model was used to forecast the trends for the next decade under several 
scenarios of US involvement in future wars. The major insights from the model are: 1) The 
population of patients and system costs are very sensitive to US involvement in future wars, 
and screening and treatment policy interventions have marginal effects in comparison; 2) In a 
very optimistic scenario, estimated PTSD prevalence among veterans in 2025 will be 10%; 3) 
During wars, resiliency-related policies are the most effective for decreasing PTSD; in a postwar 
period, there is no silver bullet to overcome the problem of PTSD; and 4) It takes a long time, on 
the order of 40 years, to vanquish the psychiatric consequences of a war.  
These insights may help the military, the VA, and other government entities identify more 
effective strategies and also interact more effectively with one another. As discussed earlier, 
PTSD is a multi-organizational problem [5] and focusing on one organization or a specific stage 
of patients’ lives can result in shifting the burden to another organization. We also would like to 
clarify that all costs estimations in the study are based on average expenditure per patients in 
military and VA healthcare facilities. The actual costs for each individual patient is much higher 
including the cascading effects of the illness on one’s personal life [5]. The illness can result in 
social exclusion, job loss, drug and alcohol abuse, or family-related problems such as divorce 
[5].  
Future studies could further validate our findings. Our work mainly describes the model as a 
flow process with few but relevant feedback loops. Future dynamic modeling studies could 
incorporate more feedback loop mechanisms. More dynamic factors can also be considered. 
For example, as changes occur in the system, treatment and screening may improve, which 
eventually will result in different behavior of the model outputs. We also followed the usual 
binary status to treat PTSD, but we acknowledge that mental illnesses almost always exist on a 
sliding scale, and to impose an on-off switch is relatively arbitrary. Despite these limitations, we 
hope the current study provides a first systematic step towards better understanding the 
consequences of PTSD policies. 
Our model is fully documented not only for investigating various policies and analyzing the 
results over the long haul but also for further development and replications. The model is 
available to be run online at https://goo.gl/Dej8wL. The historical data and model’s 
assumptions (embedded in model parameters and equations) are continually refined at the 
given web address. 
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APPENDIX 1: Data – Time Series 
 
Table A1 provides a summary of time series data used in this study. We present more details 
about these data.  
 
Table A1: Summary of time series used in the model 
No Variable Values Sources 
Military and Veterans Population 
1 Military population Figure A1 Institute of Medicine (2014) & 
D.o.D. (2015) 
2 Troops in Iraq combat zone Figure A1 D.o.D. (2012) 
3 Troops in Afghanistan combat zone Figure A1 D.o.D. (2012) 
4 Military recruitment Figure A2 D.o.D. (2014) 
5 Military separation rate Figure A2 Authors’ estimation using [D.o.D. 
(2015) & D.o.D. (2013)] and 
D.o.D. (2014). 
6 Veterans population Figure A3 Institute of Medicine (2014) & 
Richardson and Waldrop (2003) 
and Bagalman (2014) 
PTSD related variables 
7 PTSD diagnosed in military Figure A4 Institute of Medicine (2014) 
8 PTSD diagnosis rate in military  Institute of Medicine (2014) and 
Fischer (2014) 
 8.1.  Diagnosis rate of deployed Figure A4 Fischer (2014) 
 8.2.  Diagnosis rate of not-deployed Figure A4 Fischer (2014) 
9 PTSD diagnosed veterans (all) Figure A5 Institute of Medicine (2014), 
Rosenheck and Fontana (2007) 
and Hermes, Rosenheck, Desai, 
and Fontana (2012) 
 9.1.  Diagnosed; Iraq and Afghanistan 
veterans 
Figure A5 Rosenheck and Fontana (2007) 
and Hermes et al. (2012) 
 9.2.  Diagnosed; pre-2000 era veterans Figure A5 Rosenheck and Fontana (2007)  
10 PTSD diagnosis rate of veterans Figure A5 Institute of Medicine (2014) 
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Cost related variables 
11 PTSD costs in military Figure A6 Institute of Medicine (2014) 
12 PTSD costs in Veterans Affairs Figure A6 Institute of Medicine (2014) 
 
 
Military and Veterans Population 
1. Military population 
Unit: Persons 
Description: The military includes active and reserve members.  
Values: Figure A1 
Source: Institute of Medicine (2014, p. 37) data for 2004-2012. The rest of the data are 
extracted from D.o.D. (2015). 
 
2. Troops in Iraq combat zone 
Unit: Persons 
Description: The military personnel deployed to Iraq 
Values: Figure A1 
Source: The Department of Defense report, D.o.D. (2012) 
 
3. Troops in Afghanistan combat zone 
Unit: Persons 
Description: Military personnel deployed to Afghanistan 
Values: Figure A1 
Source: The Department of Defense report, D.o.D. (2012) 
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Figure A1: Total number of service members in the military (left axis) and deployment to Iraq 
and Afghanistan (right axis) for 2000-2014. 
 
 
4. Military recruitment 
Unit: Persons/year 
Description: Annual recruitment for active and reserve personnel 
Values: Figure A2 
Source: Extracted from annual Department of Defense announcement for recruiting and 
retention for fiscal years of 2000 to 2014 D.o.D. (2014). 
 
5. Military separation rate 
Unit: persons/year 
Description: Annual exit rate (separation) from the military 
Values: Figure A2 
Source: Authors’ estimation from the military population and recruitment data [D.o.D. 
(2015) and D.o.D. (2013)] and D.o.D. (2014). For year t, we assume: Military 
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separation rate(t) = Recruitment(t) – [Military population(t+1)- Military 
population(t)]. 
 
 
Figure A2: Military hiring rate (active, reserve, and total) and separation rate for 
2000-2014 
 
6. Veterans population  
Unit: Persons 
Description: All living veterans (18 years old and older) 
Values: Figure A3 
Source: Institute of Medicine (2014, p. 99) for 2010-2012. The rest of the data are 
extracted from Bagalman (2014) and Richardson and Waldrop (2003). 
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Figure A3: Total number of living veterans 
 
 
 
PTSD related variables 
7. PTSD diagnosed in military 
Unit: Persons 
Description: Number of the military service members who are diagnosed with PTSD. The 
Institute of Medicine considers a military person to have PTSD if during the year 
he/she had one inpatient stay or two outpatient visits, at least one day apart with 
the diagnosis.  
Values: Figure A4 
Source: Institute of Medicine (2014, p. 92) reports diagnosed military for 2004-2012. 
 
8. PTSD diagnosis rate in military 
Unit: Persons/Year 
Description: Annual new diagnosis of PTSD in the military  
Values: Figure A4 
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Source: Institute of Medicine (2014, p. 37) reports PTSD diagnosed in the military for 
2004-2012. The rest of the data are based on a congressional report by Fischer (2014) 
with minor adjustment to make consistent with the IOM report.   
 
Sub-categories: 
8.1. Diagnosis rate among the military members deployed to Iraq and 
Afghanistan, extracted from Fischer (2014). 
8.2. Diagnosis rate among the military members not deployed, extracted from 
Fischer (2014). 
 
 
Figure A4: PTSD Diagnosed in the military and Diagnosis Rate (new cases)  
 
 
9. PTSD diagnosed veterans 
Unit: Persons 
Description: Numbers of veterans receiving veteran affairs (VA) specialty mental health 
services for PTSD. The Institute of Medicine considers a veteran to have PTSD if 
during the year before he/she had one inpatient stay or two outpatient visits, at 
least one day apart with the diagnosis. 
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Values: Figure A5 
Source: Institute of Medicine (2014, p. 41) reports data for years 2008 and 2013. The rest 
of the data are based on Rosenheck and Fontana (2007) and Hermes et al. (2012). 
  
9.1. Veterans of Iraq and Afghanistan with PTSD 
   Source: Rosenheck and Fontana (2007) and Hermes et al. (2012) 
9.2. Veterans of Pre-2000 era with PTSD 
Note: We added up data on PTSD from wars prior to Afghanistan 
and from peace periods. A major portion of these data relates to 
Vietnam veterans.  
Source: Data extracted from Exhibit 1 of Rosenheck and Fontana 
(2007). 
 
10. PTSD diagnosis rate of veterans 
Unit: Persons/Year 
Description: Annual new diagnosis of PTSD in VA related facilities 
Values: Figure A5 
Source: Institute of Medicine (2014, p. 41) reports data for years 2008 and 2013. 
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Figure A5: PTSD diagnosed in VA and diagnosis rate (new cases per year)  
 
 
 
Cost related variables 
11. PTSD costs in military 
Unit: $ 
Description: This is only direct cost associated with a person under treatment in the 
military. The Institute of Medicine estimates this cost based on average costs per 
day for inpatient and outpatient visits related to PTSD and costs of buying drugs. 
The numbers are in real terms (inflation-adjusted) for the 2010 dollar value.  
Values: Figure A6 
Source: Institute of Medicine (2014, p. 92) 
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Description: This is only direct cost associated with a person under treatment in VA. The 
Institute of Medicine estimates this cost based on average costs per day for 
inpatient and outpatient visits related to PTSD and costs of buying drugs. The 
numbers are in real terms (inflation-adjusted) for the 2010 dollar value.  
Values: Figure A6 
Source: Institute of Medicine (2014, p. 99). 
 
 
Figure A6: PTSD direct costs in the military and VA  
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APPENDIX 2: Data - Parameters  
Parameters are assumed to be constant during the entire simulation run (2000-2025). Table A2 
provides a summary of the parameters, their values, and sources. In following, we provide more 
details about these parameters.   
 
Table A2: Summary of data used for model parameters 
N
o Parameters Value Sources 
1 Annual separation ratio 12.5
% 
Based on three estimates: DeFraites 
and Vythilingam (2011), Segal and 
Segal (2004, p. 10), and our estimation 
using Little’s Law (Little, 1961). 
 1.1. Separation ratio of ill-
undiagnosed 
18% Estimated using item 1 of this table. 
 1.2. Separation ratio of previously 
diagnosed 
33% DeFraites and Vythilingam (2011) 
 1.3. Separation ratio of ill-
diagnosed 
20% Dunbar (2013) 
2 Probability of getting PTSD given a 
trauma 
17% Martin (2014) 
3 Average number of traumas a 
deployed person experiences per year 
(traumas/year/person) 
4.5 Weighted average of items 3.1 and 3.2 
from Hoge et al. (2004) 
 3.1.  traumas/year/person in Iraq 6.21 Hoge et al. (2004)  
 3.1.  traumas/year/person in 
Afghanistan 
3.02 Hoge et al. (2004) 
4 Unhealthy recruitment ratio 0.01 Monahan, Hu, and Rohrbeck (2013) 
5 Normal fractional rate of developing 
PTSD for non-combat related reasons 
0.1% Kilpatrick et al. (2013) and 
Organization for Economic 
Cooperation Development Staff 
(OECD) (2013). 
6 Average cost per PTSD patient in 
military after 2012 
$4,50
0 
Institute of Medicine (2014) 
7 Average cost per PTSD patient in VA 
after 2012 
$6,24
4 
Institute of Medicine (2014) 
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8 Fractional death rate for veterans 
(1/year) 
0.023 Authors’ estimation based on USA 
Social Security Administration (2010) 
 8.1. Fractional death rate for Iraq and 
Afghanistan veterans  
0.023 Authors’ estimation based on USA 
Social Security Administration (2010) 
 8.2. Fractional death rate for veterans 
non-deployed  
0.023 Authors’ estimation based on USA 
Social Security Administration (2010) 
 8.3. Fractional death rate for pre-2000 
veterans 
0.030 Authors’ estimation based on USA 
Social Security Administration (2010) 
and Richardson and Waldrop (2003) 
9 Fractional death rate for military 
personnel 
0.010 Authors’ estimation based on USA 
Social Security Administration 
("Actuarial Life Table," 2015) and 
(Waldman, 2015) 
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1. Annual separation ratios  
Unit: 1/year 
Description: This is the annual exit ratio from the military for different subpopulations, 
described in sections 1.1-1.3 below. 
Value: 12.5% 
Source: DeFraites and Vythilingam (2011) estimated annual separation rate of 15% for 
the military personnel population. This means every year about 15% of military 
personnel leave the military. If we take this estimation, the average duration of 
service should be slightly less than 7 years. This is not far from the argument of 
Segal and Segal (2004, p. 10). They state that the average length of service in the 
U.S. military is less than 10 years. We also used little’s law (Little, 1961) to estimate 
the exit rates assuming relatively constant population in the military and a stable 
hiring rate (W=Average waiting time = Population/recruitment). This gives us 
W=7.8 years. Based on these sources, we assumed 8 years to be a reasonable 
estimate for the duration of service—for further validation, we conduct sensitivity 
analysis to build confidence in this assumption. This means the whole population 
of military personnel separates in the rate of 1/8=12.5%. 
   
We used different methods to estimate separation ratios for different sub-
categories:  
1.1. Separation ratio of ill-undiagnosed: This is the population that 
has PTSD but not diagnosed. We assumed that the 
military personnel get deployed for about a year (or a 
year and a half) and they have some training before 
the deployment (Institute of Medicine, 2014, p. 40). 
So it would be reasonable to assume that on average 
for people who have just developed PTSD in a combat 
zone it takes about 5.5 years (8-2.5 years) to separate. 
Thus separation ratio for this sub-population would be 
roughly 18%.  
1.2. Separation ratio of previously diagnosed: Based on DeFraites 
and Vythilingam (2011), 33% of the military personnel 
diagnosed with PTSD separate from the military in a 
year. However, a considerable portion of them (not 
necessarily all) are still ill and need care.  
14 
 
1.3. Separation ratio of ill-diagnosed: Following the quote by TSG 
Horoho: "The good news is 80% of those diagnosed 
with PTSD return to duty verifying what we in 
medicine have always known, PTSD is a treatable 
condition,” (Dunbar, 2013). Accordingly, we believe it 
is reasonable to assume that 20% get discharged very 
soon as ill, and the rest of them (13%) get discharged 
in other forms, either as healthy, or ill-undiagnosed, in 
case they only discontinued their treatment. 
 
2. Probability of getting PTSD given a trauma  
Unit: person/traumatic event 
Description: The average chance of developing PTSD if someone faces a trauma (with no 
special resiliency-related intervention) 
Value: 17% 
Source: Reported by Martin (2014) 
 
3. Average number of traumas a deployed person experiences per year  
Unit: trauma/person/year 
Description: This value varies for different wars. Hoge et al. (2004) conducted a survey on 
selected infantry units of deployed military members in Iraq and Afghanistan to 
investigate the relation of exposure to combat and mental problems including 
PTSD. Their survey presents that traumatic exposure rate is 4.26 among 1,962 
members in Afghanistan, and 8.74 among 1,709 members in Iraq. The weighted 
average (weighted based on the number of members) for traumatic events among 
all troops in Afghanistan and Iraq is 6.35. Length of deployment of multiple 
deploys, by branch of service and component as of 2010 is reported to be 16.9 
months (Committee on the Assessment of the Readjustment Needs of Military 
Personnel, Base on Health of Select Populations, & Institute of Medicine, 2013, p. 
41). Therefore, the average rate of trauma per person per year should be around 
4.5 (6.34*12/16.9).  
Value: 4.5 
Source: (Hoge et al., 2004) and authors’ estimations 
3.1. Traumas/year/person in Iraq: 
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Hoge et al. (2004) estimated 8.74 traumas per 
person happens during the deployment in Iraq. 
Based on this, annual rate will be 6.21 per person.  
3.2.  Traumas/year/person in Afghanistan 
Hoge et al. (2004) estimated 4.26 traumas per 
person happens during the deployment in Iraq. 
Based on this, annual rate will be 3.02 per person. 
 
4. Unhealthy recruitment ratio 
Unit: dimensionless 
Description: This parameter represents the ratio of new hires who are assumed to be 
PTSD free (they may have other illnesses).   
Value: 0.01 
Source: Monahan et al. (2013) reports that the incidence of PTSD in recruit trainees 
among all of the service branches in 2000-2012 was 3.3 per 1,000 person-years. 
This will be the known cases. We assume that including unknown cases, 1% might 
be a reasonable estimate. Later in sensitivity analysis we change this parameter in 
a range of [0,0.05].    
 
5. Normal fractional rate of developing PTSD for non-combat related reasons 
Unit: 1/ year 
Description: This is the chance that one develops PTSD while in the military for non-
combat related reasons. We estimate this number from civilian lives, assuming 
that the average military personnel is as resilient as an average civilian and faces 
the same rate of traumatic conditions as a civilian experiences.  
Lifetime prevalence of PTSD among U.S. adults is 7.8 percent (Kilpatrick et al., 
2013). Life expectancy is about 80 years (Organization for Economic Cooperation 
Development Staff (OECD), 2013). We roughly estimate the chance of developing 
PTSD about 0.078 over 80 years, equal to 0.1% per year per person. Overall this 
number is very low in comparison to combat related traumas which makes the 
model not sensitive to our estimation. 
Value: 0.1% /year 
Source: Authors’ estimation using (Kilpatrick et al., 2013) and (Organization for Economic 
Cooperation Development Staff (OECD), 2013) 
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6. Average cost per PTSD patient in military after 2012 
Unit: $/person 
Description: We conservatively take the 2012 value, assuming no further healthcare cost 
inflation.  
Value: $4,520 per diagnosed patient. This value is a weighted average of inpatient costs 
and outpatient costs. 
Source: Institute of Medicine (2014, p. 92) 
 
7. Average cost per PTSD patient in VA after 2012  
Unit: $/person 
Description: We conservatively take the 2012 value, assuming no further healthcare cost 
inflation.  
Value: $6,244per diagnosed patient. This value is a weighted average of inpatient costs 
and outpatient costs. 
Source: Institute of Medicine (2014, p. 99) 
8. Fractional death rate for veterans (death ratio per year for veterans) 
Unit: 1/year 
Description: We estimate this ratio based on the life expectancy of US citizens. Life 
expectancy of a 40 years old in the US is 40.4 years (death ratio: 1/40=0.025), and 
life expectancy of a 30 years old is 49.8 years (death ratio 1/50=0.02). We roughly 
estimate death ratio = 0.023 which also gives us a very good fit to data. 
Value: 0.023 
Source: Authors’ estimation from data about life expectancy in the US using USA Social 
Security Administration (2010). 
8.1. Death ratio for Iraq and Afghanistan veterans: 0.023 
8.2. Death ratio for veterans not deployed: 0.023 
8.3. Death ratio for pre-2000 veterans: Median age of pre-2000 
veterans was 57.4 in 2000 (Richardson & Waldrop, 
2003). Life expectancy of a 60 years old is 22.8 (USA 
Social Security Administration, 2010). Therefore, we 
estimated death ratio to be 0.04 (1/25). 
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9. Fractional death rate for military personnel (death ratio per year for military personnel) 
Unit: 1/year 
Description: Military service period is about 8 years (see our estimation for the 
parameter Annual separation ratio (item one in this table). If in general people 
start their military service sometime between 18-25 years old and finish sometime 
between 25-32 years old, we can estimate the chance of death in this population 
from the civilians based on the data from USA Social Security Administration. The 
average chance of death in a window of eight year life in those young periods is 
about 1.0%. The number of fatality during service in the military is relatively very 
low. For example, total of 6,607 in Iraq and Afghanistan were killed (Waldman, 
2015), the annual death of 0.02% for the whole military population.  
Value: 0.010  
Source: Authors’ estimation from the data about life expectancy in the US using USA 
Social Security Administration ("Actuarial Life Table," 2015). 
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APPENDIX 3: Model Formulation 
We list the model formulation in the same format that appears in Vensim (see the Vensim 
model, PTSD_Simulation.mdl, in the supplementary files). Model equations are listed for (a) 
simulation set-up, (b) model’s main equations, and (c) experimental set-up.  
 
(a) Simulation set-up 
1. INITIAL TIME  = 2000 
Units: year  
2. FINAL TIME  =  2025 
  Units: year  
3. TIME STEP  = 0.25 
Units: year  
4. SAVEPER  =  TIME STEP 
Units: year 
 
(b) Model’s main equations 
5. "Healthy Military (PMH)"=  
INTEG (Recruitment of healthy-Developing illness in CZ-Developing illness not in CZ -
PMH death rate-Rate of healthy separation, Initial PMH) 
  Units: persons 
6. "Healthy Veterans (PVH)"= 
INTEG (Rate of healthy separation+ Return of healthy veterans with PTSD history-Death 
rate of PVH, Initial PVH) 
Units: persons 
7. "PM,ID: Ill-Diagnosed Military NotDeployed"=  
INTEG (Rate of diagnosis during service NotDeployed- PMIDn death rate-Separation of 
NotDeployed with PTSD -"Quitting treatment rate for not-deployed military", "initial 
PM,ID NotDeployed") 
Units: persons 
8. "PM,ID: Ill-Diagnosed Military OEF & OIF"= 
INTEG ( "Rate of diagnosis during service OEF & OIF"-PMID death rate-"Separation of 
OEF & OIF with PTSD"-"Quitting treatment rate for OEF & OIF in military", "initial PMID 
OEF&OIF") 
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Units: persons 
9. "PM,IU: Ill-Undiagnosed Military NotDeployed"=  
INTEG (Rate of developing illness NotDeployed+ Recruitment of unhealthy- PMIUn 
death ratio -Rate of diagnosis during service NotDeployed- Separation of NotDeployed 
with unknown illness, initial PMU NotDeployed) 
Units: persons 
10. "PM,IU: Ill-Undiagnosed Military OEF & OIF"=  
INTEG ("Developing illness OEF&OIF"-PMIU death rate-"Rate of diagnosis during service 
OEF & OIF"-"Separation of OEF & OIF with unknown illness", "initial PMIU OEF&OIF") 
Units: persons 
11. "PV,ID: Ill-Diagnosed Veterans of Pre-2000"=  
INTEG ("Rate of diagnosis after service of Pre-2000"-"Death rate of PV,ID of Pre-2000"-
"Quitting treatment rate for Pre-2000", "initial PVID Pre-2000") 
Units: persons 
12. "PV,ID: Veterans NotDeployed"=  
INTEG (Separation of NotDeployed with PTSD+ Rate of diagnosis after service 
NotDeployed -"Quitting treatment rate for not-deployed veterans"-"Death rate of PV,ID 
of NotDeployed", "initial PV,ID NotDeployed") 
Units: persons 
13. "PV,ID: Veterans of OEF & OIF"=  
INTEG ("Rate of diagnosis after service OEF & OIF"+ "Separation of OEF & OIF with 
PTSD"-"Death rate of PV,ID of OEF&OIF"-"Quitting treatment rate for OEF & OIF 
veterans", "initial PVID OEF&OIF") 
Units: persons 
14. "PV,IU: Ill-Undiagnosed Veterans NotDeployed"=  
INTEG (Separation of NotDeployed with unknown illness-"Death rate of PV,IU of Not 
deployed"-Rate of diagnosis after service NotDeployed+ Separation not deployed with 
Ineffective treatment, initial VIU NotDeployed) 
Units: persons 
15. "PV,IU: Ill-Undiagnosed Veterans OEF & OIF"=  
INTEG "Separation of OEF & OIF with unknown illness"-"Death rate of PV,IU of 
OEF&OIF"-"Rate of diagnosis after service OEF & OIF"+ "Separation OEF & OIF with 
Ineffective treatment", "initial PVIU OEF&OIF") 
Units: persons 
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16. "PV,IU: Ill-Undiagnosed Veterans of Pre-2000"=  
INTEG (-"Death rate of PV,IU of Pre-2000"-"Rate of diagnosis after service of Pre-2000", 
"initial VAU Pre-2000") 
Units: persons 
17. "PM,ID: Ill-Diagnosed Military"= 
"PM,ID: Ill-Diagnosed Military NotDeployed"+"PM,ID: Ill-Diagnosed Military OEF & OIF" 
Units: persons 
18. "initial PM,ID NotDeployed"= 
Initial rate of diagnosis of nondeployed/(Quitting treatment ratio in Military+ Separation 
ratio of people who have had PTSD) 
Units: persons 
19. initial PMU NotDeployed= 
"initial PM,ID NotDeployed"*(Separation ratio of people who have had PTSD+ Quitting 
treatment ratio in Military)/Ratio revealing symptoms military 
  Units: persons 
20. Initial PMH= 
Initial military population - ("initial PMIU OEF&OIF"+ "initial PMID OEF&OIF"+ initial 
PMU NotDeployed +"initial PM,ID NotDeployed") 
Units: persons 
21. Initial PVH= 
  initial Veterans population-"initial PVID OEF&OIF"-"initial PVIU OEF&OIF" 
-initial VIU NotDeployed-"initial VAU Pre-2000"-"initial PVID Pre-2000"-"initial PV,ID 
NotDeployed" 
Units: persons 
22. Post Treatment Stage Military NotDeployed=  
INTEG ("Quitting treatment rate for not-deployed military"-"Separation not-deployed 
veterans with unknown status but history of PTSD",0) 
Units: persons 
23. "Post Treatment Stage Military OEF & OIF"=  
INTEG ("Quitting treatment rate for OEF & OIF in military"-"Separation OEF & OIF 
veterans with unknown status but history of PTSD", 0) 
Units: persons 
24. "Rate of diagnosis during service OEF & OIF"= 
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"PM,IU: Ill-Undiagnosed Military OEF & OIF"*Ratio revealing symptoms military 
Units: persons/year 
25. Rate of diagnosis during service NotDeployed= 
Min("PM,IU: Ill-Undiagnosed Military NotDeployed"/Min time to screen, A*"Rate of 
diagnosis during service OEF & OIF"+ B) 
Units: persons/year 
26. "(3) Rate of diagnosis during service"= 
Rate of diagnosis during service NotDeployed+"Rate of diagnosis during service OEF & 
OIF" 
Units: persons/year 
27. Diagnosis multiplier= 
(K*"PM,ID: Ill-Diagnosed Military")^Alpha 
Units: Dmnl 
28. Ratio revealing symptoms for pre2000 veterans= 
Diagnosis multiplier*"Ratio revealing symptoms post-military" 
Units: 1/year 
29. "Rate of diagnosis after service of Pre-2000"= 
"PV,IU: Ill-Undiagnosed Veterans of Pre-2000"*Ratio revealing symptoms for pre2000 
veterans 
Units: persons/year 
30. "Rate of diagnosis after service OEF & OIF"= 
"PV,IU: Ill-Undiagnosed Veterans OEF & OIF"*"Ratio revealing symptoms post-military" 
Units: persons/year 
31. Rate of diagnosis after service NotDeployed= 
"PV,IU: Ill-Undiagnosed Veterans NotDeployed"*"Ratio revealing symptoms post-
military" 
Units: persons/year 
32. "(8) Rate of diagnosis after service"= 
"Rate of diagnosis after service of Pre-2000"+"Rate of diagnosis after service OEF & 
OIF"+ Rate of diagnosis after service NotDeployed 
Units: persons/year 
33. "Death rate of PV,ID of NotDeployed"= 
"Death ratio for PV,ID NotDeployed"*"PV,ID: Veterans NotDeployed" 
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Units: persons/year 
34. "Death rate of PV,ID of OEF&OIF"= 
"Death ratio for PV,ID of Veterans of OEF & OIF"*"PV,ID: Veterans of OEF & OIF" 
Units: persons/year 
35. "Death rate of PV,ID of Pre-2000"= 
"Death ratio for PV,ID Pre-2000"*"PV,ID: Ill-Diagnosed Veterans of Pre-2000" 
Units: persons/year 
36. "Death rate of PV,IU of Not-deployed"= 
"Death ratio for PV, IU NotDeployed"*"PV,IU: Ill-Undiagnosed Veterans NotDeployed" 
Units: persons/year 
37. "Death rate of PV, IU of OEF&OIF"= 
"Death ratio for PV, IU of Veterans of OEF & OIF"*"PV, IU: Ill-Undiagnosed Veterans OEF 
& OIF" 
Units: 1/year 
38. "Death rate of PV,IU of Pre-2000"= 
"Death ratio for PV, IU Pre-2000"*"PV,IU: Ill-Undiagnosed Veterans of Pre-2000" 
Units: 1/year 
39. Death rate of PVH= 
Death ratio for PVH*"Healthy Veterans (PVH)" 
Units: 1/year 
40. PMH death rate= 
Death ratio in military*"Healthy Military (PMH)" 
Units: persons/year 
41. PMID death rate= 
Death ratio in military*"PM,ID: Ill-Diagnosed Military OEF & OIF" 
Units: persons/year 
42. PMIU death rate= 
Death ratio in military*"PM,IU: Ill-Undiagnosed Military OEF & OIF" 
Units: persons/year 
43. PMIUn death ratio= 
Death ratio in military*"PM,IU: Ill-Undiagnosed Military NotDeployed" 
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Units: persons/year 
44. PMIDn death rate= 
Death ratio in military*"PM,ID: Ill-Diagnosed Military NotDeployed" 
Units: persons/year 
45. total death rate in military= 
PMH death rate+ PMID death rate+ PMIU death rate+ PMIUn death ratio+ PMIDn death 
rate 
Units: persons/year 
46. PMH in CZ= 
"Healthy Military (PMH)"*"Ratio deployed to combat zone (CZ)" 
Units: (Trauma/persons)/year 
47. Trauma experienced by PMH= 
PMH in CZ*Trauma rate per year per person in CZ 
Units: Trauma/year 
48. Chance of developing PTSD given CZ trauma= 
Normal chance of developing PTSD in CZ/Resiliency effect 
Units: persons/Trauma 
49. Chance of developing PTSD in NON CZ= 
Normal chance of developing PTSD in NON CZ/Resiliency effect 
Units: 1/year 
50. Developing illness in CZ= 
Trauma experienced by PMH*Chance of developing PTSD given CZ trauma 
Units: persons/year 
51. PMH not in CZ= 
"Healthy Military (PMH)"*(1-"Ratio deployed to combat zone (CZ)") 
Units: persons 
52. Developing illness not in CZ= 
Chance of developing PTSD in NON CZ*PMH not in CZ 
Units: persons/year 
53. "Developing illness OEF&OIF"= 
Developing illness in CZ 
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Units: 1/year 
54. Separation of NotDeployed with unknown illness= 
"PM,IU: Ill-Undiagnosed Military NotDeployed"*Separation ratio of ill undiagnosed 
service members 
Units: persons/year 
55. "Separation of OEF & OIF with unknown illness"= 
"PM,IU: Ill-Undiagnosed Military OEF & OIF"*Separation ratio of ill undiagnosed service 
members 
Units: persons/year 
56. Separation of NotDeployed with PTSD= 
Separation ratio of people who have had PTSD*"PM,ID: Ill-Diagnosed Military 
NotDeployed" 
Units: persons/year 
57. "Separation of OEF & OIF with PTSD"= 
Separation ratio of people who have had PTSD*"PM,ID: Ill-Diagnosed Military OEF & 
OIF" 
Units: persons/year 
58. Ill exits from military= 
Separation of NotDeployed with unknown illness +"Separation of OEF & OIF with 
unknown illness" +Separation of NotDeployed with PTSD +"Separation of OEF & OIF 
with PTSD" 
Units: 1/year 
59. "Separation not-deployed veterans with unknown status but history of PTSD" = 
Post Treatment Stage Military NotDeployed*Separation ratio with history of PTSD 
Units: persons/year 
60. "Separation OEF & OIF veterans with unknown status but history of PTSD" =  
"Post Treatment Stage Military OEF & OIF"*Separation ratio with history of PTSD 
Units: persons/year 
61. Separation with histroy of PTSD but current unknown status= 
"Separation not-deployed veterans with unknown status but history of PTSD" 
+"Separation OEF & OIF veterans with unknown status but history of PTSD" 
Units: persons/year 
62. "Estimate of rate of healthy separation for pre-2014"= 
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Max (0,DELAY1i(exit data(Time),data adjustment delay,Initial rate of healthy 
separation)-Ill exits from military-Separation with histroy of PTSD but current unknown 
status- total death rate in military) 
Units: persons/year 
Comment: The data reports final year death numbers. With a half a year delay we 
assume death is uniformly distributed over the year. 
63. "PM,IU: Ill-Undiagnosed Military"= 
"PM,IU: Ill-Undiagnosed Military NotDeployed"+"PM,IU: Ill-Undiagnosed Military OEF & 
OIF" 
Units: persons 
64. Service members with PTSD= 
"PM,ID: Ill-Diagnosed Military" +"PM,IU: Ill-Undiagnosed Military" 
Units: persons 
65. Service members with history of PTSD and current unknown status= 
Post Treatment Stage Military NotDeployed+"Post Treatment Stage Military OEF & OIF" 
Units: persons 
66. Total number of service members= 
"Healthy Military (PMH)"+Service members with PTSD+ Service members with history of 
PTSD and current unknown status 
Units: persons 
67. Rate of healthy separation= 
IF THEN ELSE(Time>2014 , "Estimate of rate of healthy separation for post-2014", 
"Estimate of rate of healthy separation for pre-2014") 
Units: persons/year 
68. Total exit from military= 
Rate of healthy separation+ Ill exits from military+ Separation with history of PTSD but 
current unknown status+ total death rate in military 
Units: persons/year 
69. "Estimate of rate of recruitment for post-2014"= 
max(0,Military size gap/Time to fill the gap+ Total exit from military) 
Units: persons/year 
70. Healthy separation not deployed with history of PTSD= 
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ratio of effective treatment*"Separation not-deployed veterans with unknown status 
but history of PTSD" 
Units: persons/year 
71. "Healthy separation OEF & OIF with history of PTSD"= 
ratio of effective treatment*"Separation OEF & OIF veterans with unknown status but 
history of PTSD" 
Units: persons/year 
72. PTSD Cost for Diagnosed Military NotDeployed= 
"PM,ID: Ill-Diagnosed Military NotDeployed"*PTSD Cost per Diagnosed Military(Time) 
Units: dollar 
73. “PTSD Cost for Diagnosed Military OEF & OIF"= 
"PM,ID: Ill-Diagnosed Military OEF & OIF"*PTSD Cost per Diagnosed Military (Time) 
Units: dollar 
74. PTSD Cost for Diagnosed Veterans NotDeployed= 
PTSD Cost per Diagnosed Veterans (Time)*"PV,ID: Veterans NotDeployed" 
Units: dollar 
75. "PTSD Cost for Diagnosed Veterans OEF & OIF"= 
PTSD Cost per Diagnosed Veterans (Time)*"PV,ID: Veterans of OEF & OIF" 
Units: dollar 
76. "PTSD Cost for Diagnosed Veterans Pre-2000"= 
PTSD Cost per Diagnosed Veterans (Time)*"PV,ID: Ill-Diagnosed Veterans of Pre-2000" 
Units: dollar 
77. PTSD Cost in Military= 
"PM,ID: Ill-Diagnosed Military"*PTSD Cost per Diagnosed Military (Time) 
Units: dollar 
78. "PV,ID: Ill-Diagnosed Veterans"= 
"PV,ID: Ill-Diagnosed Veterans of Pre-2000"+"PV,ID: Veterans of OEF & OIF"+"PV,ID: 
Veterans NotDeployed" 
Units: persons 
79. PTSD Cost in VA= 
PTSD Cost per Diagnosed Veterans (Time)*"PV,ID: Ill-Diagnosed Veterans" 
Units: dollar 
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80. "PV,IU: Ill-Undiagnosed Veterans"= 
"PV,IU: Ill-Undiagnosed Veterans of Pre-2000"+"PV,IU: Ill-Undiagnosed Veterans OEF & 
OIF"+ "PV,IU: Ill-Undiagnosed Veterans NotDeployed" 
Units: persons 
81. Veterans with PTSD= 
"PV,ID: Ill-Diagnosed Veterans"+"PV,IU: Ill-Undiagnosed Veterans" 
Units: persons 
82. Total number of veterans= 
"Healthy Veterans (PVH)"+Veterans with PTSD 
Units: persons 
83. PTSD prevalence among Veterans= 
Veterans with PTSD/Total number of veterans 
Units: Dmnl 
84. PTSD prevalence in Military= 
Service members with PTSD/Total number of service members 
Units: Dmnl 
85. "Quitting treatment rate for not-deployed military"= 
Quitting treatment ratio in Military*"PM,ID: Ill-Diagnosed Military NotDeployed" 
Units: 1/year 
86. "Quitting treatment rate for not-deployed veterans"= 
Quitting treatment ratio for veterans*"PV,ID: Veterans NotDeployed" 
Units: persons/year 
87. "Quitting treatment rate for OEF & OIF in military"= 
Quitting treatment ratio in Military*"PM,ID: Ill-Diagnosed Military OEF & OIF" 
Units: persons/year 
88. "Quitting treatment rate for OEF & OIF veterans"= 
Quitting treatment ratio for veterans*"PV,ID: Veterans of OEF & OIF" 
Units: persons/year 
89. "Quitting treatment rate for Pre-2000"= 
Quitting treatment ratio for veterans*"PV,ID: Ill-Diagnosed Veterans of Pre-2000" 
Units: persons/year 
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90. Rate of developing illness NotDeployed= 
Developing illness not in CZ 
Units: persons/year 
91. Recruitment of healthy= 
(1-Unealthy recruitment ratio)*Recruitment 
Units: persons/year 
92. Recruitment of unhealthy= 
Unhealthy recruitment ratio*Recruitment 
Units: persons/year 
93. Separation of healthy Veterans with history of PTSD= 
"Healthy separation OEF & OIF with history of PTSD"+ Healthy separation not deployed 
with history of PTSD 
Units: persons/year 
94. Return of healthy veterans with PTSD history= 
Separation of healthy Veterans with history of PTSD+ "Quitting treatment rate for OEF & 
OIF veterans" 
Units: persons/year 
95. Separation not deployed with Ineffective treatment= 
(1-ratio of effective treatment)*"Separation not-deployed veterans with unknown 
status but history of PTSD" 
Units: persons/year 
96. "Separation OEF & OIF with Ineffective treatment"= 
(1-ratio of effective treatment)*"Separation OEF & OIF veterans with unknown status 
but history of PTSD" 
Units: persons/year 
97. Separation of Ill Undiagnosed Veterans with history of PTSD= 
"Separation OEF & OIF with Ineffective treatment"+ Separation not deployed with 
Ineffective treatment 
Units: persons/year 
 
(c) Experimental set-up 
98. Resiliency effect= 
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Normal Resiliency*max (0, 1+Smooth (step(Percent Change in Resiliency/100,Policy 
implementation time), Time to implement policy)) 
Units: Dmnl 
99. Ratio revealing symptoms military= 
Normal Ratio revealing symptoms military* max(0,1+Smooth(step(Percent Change in 
Screening/100,Policy implementation time),Time to implement policy)) 
Units: 1/year 
100. Quitting treatment ratio in Military= 
Normal quitting ratio in Military*max(0,1+Smooth(step(Percent Change in Treatment in 
Military/100,Policy implementation time),Time to implement policy)) 
Units: 1/year 
101. Deployment to a hypothetical war= 
Intensity of a hypothetical war in comparison to Iraq*Trauma multiplier in 
Iraq*"Deployment during Iraq war (data)"(Time-"Time for an Iraq-like war") 
Units: Dmnl 
102. Steady state deployment= 
IF THEN ELSE (Time>2015, Intensity in steady state in comparison to Iraq*Deployment 
ratio in Iraq during the war*Trauma multiplier in Iraq,0) 
Units: Dmnl 
103. "Deployment to CZ-like areas post-2014"= 
Deployment to a hypothetical war+ Steady state deployment 
Units: persons 
104. Desired number of service members= 
Total service members in 2014 
Units: Dmnl 
105. "Ratio deployed to combat zone (CZ)"= 
IF THEN ELSE(Time<=2015,"Deployment to CZ areas pre-2014 (OEF & OIF)" 
(Time),"Deployment to CZ-like areas post-2014") 
Units: Dmnl 
106. "Estimate of rate of healthy separation for post-2014"= 
"Healthy Military (PMH)"*Separation ratio of healthy service members 
Units: persons/year 
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107. "Estimate of rate of recruitment for post-2014"= 
max(0,Military size gap/Time to fill the gap+Total exit from military) 
Units: persons/year 
108. Military size gap= 
Desired number of service members-Total number of service members 
Units: year 
109. Recruitment= 
IF THEN ELSE(Time>2014,"Estimate of rate of recruitment for post-2014","Recruitment data 
pre-2014"(Time)) 
Units: persons/year 
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APPENDIX 4: Model Calibration  
In any modeling, the overall goal is to estimate as many parameters as possible directly from 
data. But sometimes there are some parameters for which data are not gathered, reliable data 
are not available, or we could not find them. In these situations, we can statistically calibrate the 
model to data by estimating the unknown parameters.  
In simple words, calibration is about using statistical methods to estimate parameter values 
for which we do not have data. It is important to conduct sensitivity analysis for estimated 
parameters, examining the model’s robustness to changes in the estimations.  
We conduct one of the most accurate calibration procedures, partial model 
calibration/testing (Homer, 2012). In the partial model calibration, different pieces of the model 
are separately calibrated. This method is known to provide relatively robust estimates and 
decrease the chances of over-fitting the model. It also helps understand which parts of the model 
are better representative of the reality and which parts are producing more errors.  
 
4.1. Unknown parameters 
Table A3 presents estimated parameters through calibration as well as the respective calibration 
steps. Overall, we have conducted six different calibration procedures (calibration procedures 1-
6) for the total of eight unknown parameters. Sensitivity of our results to parameter estimations 
is presented in APPENDIX 5. 
  
Table A3: Estimated (unknown) parameters in the model 
No Parameter Value Calibration step 
1 Quitting treatment ratio in military 0.125 Calibration 
procedure 1 
2 Quitting treatment ratio in VA 0.145 Calibration 
procedure 2 
3 Ratio revealing symptoms in military 0.043 Calibration 
procedure 3 
4 Ratio revealing symptoms for veterans 0.103 Calibration 
procedure 4 
5 Effects of Iraq/Afghanistan wars on 
revealing symptoms for pre-2000  
x = (K*PM,ID) α 
 
 
K= 1.38E-06  
α = 0.4959 
Calibration 
procedure 5 
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6 Rate of PTSD diagnosis for non-combat 
related reasons 
y = yc+ a*Rate of diagnosis OEF & 
OIF  
y < PM,IU 
 
 
yc = 2267.8 
a = 0.0936 
Calibration 
procedure 6 
 
1. Quitting treatment ratio in military  
Unit: 1/year 
Description: Since there is no reliable data on effective treatment (Institute of Medicine, 
2014), we focus on the number of people who stop receiving treatment. This ratio 
presents the portion of the military personnel who were receiving PTSD treatment 
in the previous time period (t-1), and are no longer under treatment (at time t). 
The degree of freedom (DOF) in this producer is one (described in more detail in 
calibration procedure 1), which means we have a highly accurate estimation.    
Source: Calibration procedure 1 (DOF=1)  
Value: 0.1347 
 
2. Quitting treatment ratio in VA  
Unit: 1/year 
Description: Since there is no reliable data on effective treatment (Institute of Medicine, 
2014, p. 33), we focus on the number of people who stop receiving treatment. This 
ratio is in fact veterans who were receiving PTSD treatment in VA facilities in the 
previous time period (t-1), and are no longer under treatment (at time t). Similar 
with the previous parameter, the DOF in this producer is one (described in more 
detail in calibration procedure 2), which means we have a highly accurate 
estimation.   
Source: Calibration procedure 2 (DOF=1).    
Value: 0.1457 
 
3. Ratio revealing symptoms in military 
Unit: 1/year 
Description: Not all military members with PTSD show symptoms while serving in the 
military. There is no data on how many people have PTSD and are undiagnosed. 
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Thus, we estimated the rate at which undiagnosed military personnel turn to 
diagnosed military personnel through calibration.  
Source: Calibration procedure 3 (DOF=1).      
Value: 0.0415 
 
4. Ratio revealing symptoms post-military (Iraq and Afghanistan) 
Unit: 1/year 
Description: Many veterans who have PTSD gradually show their symptoms of illness. We 
estimated at rate at which undiagnosed veterans turn to diagnosed veterans 
through calibration.   
Source: Calibration procedure 4 (DOF=1)    
Value: 0.1001 
 
5. Effects of Iraq/Afghanistan wars on revealing symptoms for pre-2000 veterans 
Unit: 1/year 
Description: Ratio of revealing symptoms for pre-2000 veterans is not necessarily the 
same as the ratio for more recent wars. Some veterans who served in the military 
before 2000 and developed PTSD may show symptoms of illness after 2000. 
Anecdotal evidence and the paper by Hermes et al. (2012) suggest that the 
number of Vietnam veterans with PTSD is still increasing. One argument is that the 
war in Iraq and Afghanistan had triggered old memories exacerbating the situation 
of these veterans. This is one of the reasons we may see a growth in PTSD of pre-
2000 veterans. Accordingly, we assumed:  
 
Ratio of revealing symptoms post-military for pre-2000 wars =  
Ratio of revealing symptoms post-military * Effects of Iraq/Afgh wars =   
Ratio of revealing symptoms post-military * [K*PM,ID α] 
In this formulation, the term [K*PM,ID α] is used to represent the multiplier effect 
of recent wars. The logic is that with more PTSD cases from recent wars, we will 
hear proportionally more news about PTSD which affects new diagnosis in an 
increasing but declining slop.  
Source: Calibration procedure 5 (DOF=2)    
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Values: K= 1.14E-3; α = 0.51 
 
6. Rate of PTSD diagnosis for non-combat related reasons  
Unit: Persons/year 
Description: Ratio of revealing symptoms for people not deployed have been increasing. 
We presented this with a constant parameter (representing issues unrelated to 
wars) plus a linear term representing the growth trend. This growth trend is 
partially due to more screening and more attention to PTSD or hiring individuals 
with illness.  
 
Rate of PTSD diagnosis for non-combat related reasons =  
= yc + a*Rate of diagnosis OEF & OIF + b  < PM, IU 
Source: Calibration procedure 6 (DOF=2)    
Values: yc = 2267.8; a = 0.0936  
 
 
4.2. Calibration procedures: 
 
Calibration procedure 1:  
• Input: Rate of diagnosis [of PTSD] in Military ( 
• Table A1, item 8.1), Separation ratio of ill-diagnosed (Table A2, item 1-3), and fractional 
death rate for military personnel (Table A2, item 9). 
• Payoff function: maximize the fit between the data and simulation of PM,ID.  
• Outcomes: the only unknown parameter, Quitting treatment ratio in military (Table A3, 
item 1).  
• DOF: 1 
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(a): Model sub-structure  
(Estimated parameter is in red, data in green) 
  
(b) Matching outcome 
Figure A7: Calibration procedure 1 including model sub-structure (a), and the matching 
outcome (b).  
Calibration outcome: Quitting treatment ratio in military = 0.125 
 
 
Calibration procedure 2:  
• Input: Rate of diagnosis in VA ( 
• Table A1, item 10), fractional death rate for veterans (Table A2, item 8).   
• Payoff function: maximize the fit between the data and simulation of PV,ID.  
• Outcomes: the only unknown parameter, Quitting treatment ratio in VA (Table A3, item 
2) 
• DOF: 1 
 
PM,ID: Ill-Diagnosed
MilitaryRate of diagnosis
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Quitting treatment
rate in Military
Quitting treatment
ratio in Military
Separation ratio for
ill-diagnosed
death rate of
PM,ID
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(a): Model sub-structure  
(Estimated parameter is in red, data in green) 
 
(b) Matching outcome 
Figure A8: Calibration procedure 2 including model sub-structure (a), and the matching 
outcome (b).  
Calibration outcome: Quitting treatment ratio in VA = 0.145 
 
 
Calibration procedure 3:  
• Input: Deployment to Combat Zone ( 
• Table A1, items 2 and 3), Chance of developing PTSD given combat zone trauma, trauma 
rate per year per person in combat zone (Table A2, items 2 and 3), death ratio of PM,IU 
(assumed equal to fractional death rate for military personnel; Table A2, item 9), and 
Separation of ill undiagnosed service members (Table A2, item 1.1). Initial PMIU OEF & 
OIF is zero since simulation starts before these wars. PMH is calculated endogenously 
using recruitment rate and the military population ( 
PV,ID: Ill-Diagnosed
VeteransRate of diagnosis
after service
death rate
fractional death
rate for veterans
Quitting treatment
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Quitting treatment
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600,000
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300,000
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"PV,ID: Ill-Diagnosed Veterans" : Simulation
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• Table A1, items 4 and 1).  
• Payoff function: maximize the fit between the data and simulation of Diagnosis rate of 
military personnel served in OIF and OEF. 
• Outcomes: the only unknown parameter, Ratio revealing symptoms in military (Table 
A3, item 3) 
• DOF: 1 
 
 
(a): Model sub-structure 
(Estimated parameter is in red, data in green) 
 
(b) Matching outcome 
Figure A9:  Calibration procedure 3 including model sub-structure (a), and the matching 
outcome (b).  
Calibration outcome: Ratio revealing symptoms in military = 0.043  
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Calibration procedure 4:  
• Input: Death ratios for PV,IU and PV,ID of Veterans of OEF and OIF (assumed to be equal 
to Fractional death rate for veterans; Table A2, item 8). In addition, Separation of ODF 
and OIF are calculated from the previous calibrated sub-structures (calibration 
procedure 3 and calibration procedure 1). Stopping treatment for veterans is the 
outcome of calibration procedure 2.  
• Payoff function: maximize the fit between the data and simulation of OEF and OIF 
veterans diagnosed with PTSD. 
• Outcomes: The only unknown parameter, Ratio revealing symptoms for 
Iraq/Afghanistan veterans (Table A3, item 4). 
• DOF: 1 
 
 
(a): Model sub-structure  
(Estimated parameter is in red, data in green, the results of previous calibration 
procedures in blue) 
 
(b) Matching outcome  
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Figure A10: Calibration procedure 4 including model sub-structure (a), and the matching 
outcome (b).  
Calibration outcome: Ratio revealing symptoms for Iraq/Afghanistan veterans = 0.103 
 
 
Calibration procedure 5:  
• Input: PM,ID (PTSD diagnosed in military,  
• Table A1, item 7), Death ratios for PV,IU and PV,ID of Veterans of pre-2000 wars 
(assumed to be equal to Fractional death rate for veterans; Table A2, item 8), Initial 
PVID ( 
• Table A1, item 9.2). In addition, ratio revealing symptoms post military and stopping 
treatment for veterans is the outcomes of calibration procedures 2 and 4.  
• Payoff function: maximize the fit between the data and simulation of PTSD Diagnosed 
veterans with pre-2000.  
• Outcomes: Effects of Iraq/Afghanistan wars on revealing symptom for pre-2000 
Veterans. 
• Assumption: We first roughly estimated the initial value of VIU to limit potential values 
for k and α. Based on the population of the Vietnam war veterans and estimated ratios 
of PTSD, we set the initial value to be equal to 5 million.  
• DOF: 1 (after making the assumption for the initial value). 
• Note: We later conducted sensitivity analysis on the value of VIU.  With 2DOF 
optimization, Vensim suggest the initial value to be equal to 5.4 million veterans which 
is very close to our initial assumption. The final results do not change when we change 5 
to 5.4 million and even with ± 1 more million shift in this value.  
 
 
(a): Model sub-structure  
(Estimated parameter is in red, data in green, the results of previous calibration procedures in 
blue) 
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(b) Matching outcome 
Figure A11: Calibration procedure 5 including model sub-structure (a), and the matching 
outcome (b).  
Calibration outcomes: K= 1.38E-06 and α = 0.4959 
 
 
Calibration procedure 6:  
• Input: Diagnosis rate of the military personnel deployed to Iraq and Afghanistan ( 
• Table A1, item 8.1) 
• Payoff function: maximize the fit between the data and simulation of Diagnosis rate of 
the military personnel who did not deploy.  
• Outcomes: parameters to estimate diagnosis rate of non-combat related PTSD  
• Assumption:  
y = yc+ a*Rate of diagnosis OEF & OIF        < PM,IU 
• DOF: 1 
 
 
400,000
300,000
200,000
100,000
0
2000 2002 2004 2006 2008 2010 2012 2014
Time (year)
"PV,ID: Ill-Diagnosed Veterans of Pre-2000" : Simulation
"PV,ID: Ill-Diagnosed Veterans of Pre-2000" : Data
Rate of diagnosis
OEF & OIF
y: Diagnosis rate of
military personnel who
did not deploy
yc: Constant term of
Diagnosis rate
a: Avearge effect of
OEF & OIF diagnosis
41 
 
(a): Model sub-structure  
(Estimated parameter is in red, data in green) 
 
(b) Matching outcome 
Figure A12: Calibration procedure 5 including model structure (a), and the matching outcome 
(b). Note: Calibration outcome: yc = 2267.8 & a = 0.0936 
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APPENDIX 5: Model Validation and Sensitivity Analysis 
We report the model’s fidelity in replicating the data. Figure A13 shows the model outcomes in 
comparison with the data for variables: PTSD diagnosed cases in military, PTSD rate of diagnosis 
in military during service in Iraq or Afghanistan, PTSD rate of diagnosis in Military (non-deployed 
military personnel), PTSD diagnosed cases in VA, PTSD diagnosed cases in VA (pre-2000), and 
PTSD diagnosed cases in VA (post-2000 wars, Iraq and Afghanistan).  
 
  
  
  
Figure A13: Replication of the data  
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The model replicated the data with a high correlation. This is not a surprise since our model 
mainly focuses on the physics of the system, which is the flow of people. What technically 
validates the model is the simple logical flow in the model—the logic behind the inflows and 
outflows of the stock variables in the model, see the Vensim model, PTSD_Simulation.mdl, in the 
supplementary files).  
 
We acknowledge the limitations of building complex models like the one we developed. To 
ensure the reliability of the model’s outputs, we conduct sensitivity analysis on the estimated 
parameters and the ones that we doubt about (given the uncertainty in the data). Here we 
demonstrate change the value of those parameters (by ±50%) in our second scenario (S2: 2% 
deployment to intense/combat zones, see Section 3.1 in the article), and examine how the model 
outputs (PTSD prevalence in military and VA) vary. The results are qualitatively similar for 
scenarios 1 and 3, or anything between. Results are provided in Table A4. We also include 
sensitivity results for changing all parameters at a time in the ranges of ±25% and ±50%, reported 
in Table A5.   
 
Table A4: Sensitivity analysis results 
No
. Parameter 
Input  Outputs 
Comments 
Change in the parameter 
results in … Change in 
parameter 
 Change 
in 
military 
PTSD 
Prevalen
ce (Y1) 
Change 
in 
veterans 
PTSD 
Prevalen
ce (Y2) 
1 Separation ratio of ill-
diagnosed  
±50%  10% - 
11% 
10% - 
10% 
±0.5 percent point change 
in Y1; 0 percent point 
change in Y2. 
2 Average number of 
traumas a deployed 
person experiences per 
year 
(traumas/year/person) 
±50%  7% - 14% 10%-10% ±3.5 percent point change 
in Y1; 0 percent point 
change in Y2. 
3 Unhealthy recruitment 
ratio 
 
[0%-5%]*  10% - 
13% 
10% - 
10% 
±1.5 percent point change 
in Y1; 0 percent point 
change in Y2. 
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* In the base run, the model assumes 1% unhealthy recruitment (people have a history of 
PTSD). For this parameter, we test a much wider range, due to some speculations about the 
correct value of this parameter.  
 
Simulation results are also reported in Figure A14, showing 50%, 75%, 95%, and 100% intervals 
based on 200 times Monte Carlo simulations.  
 
  
(a) Sensitivity of PTSD prevalence in military and VA to ±50% change in parameter “Separation ratio of ill-diagnosed” 
ase u
50% 75% 95% 100%
PTSD prevalence in Military
0.3
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Time (year)
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50% 75% 95% 100%
PTSD prevalence among Veterans
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4 Chance of developing 
PTSD for non-combat 
related reasons 
±50%  10% - 
10% 
10% - 
10% 
0 percent point change in 
Y1; 0 percent point 
change in Y2. 
5 Quitting treatment ratio 
in military 
±50%  10% - 
10% 
10% - 
10% 
0 percent point change in 
Y1; 0 percent point 
change in Y2. 
6 Quitting treatment ratio 
in VA 
±50%  10% - 
10% 
9% - 11% 0 percent point change in 
Y1; ±1 percent point 
change in Y2. 
7 Ratio revealing 
symptoms in military 
±50%  10% - 
10% 
10% - 
10% 
0 percent point change in 
Y1;  
0 percent point change in 
Y2. 
8 Ratio revealing 
symptoms for veterans 
±50%  10% - 
10% 
9% - 11% 0 percent point change in 
Y1; ±1 percent point 
change in Y2. 
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(b) Sensitivity of PTSD prevalence in military and VA to ±50% change in parameter “Average number of traumas a 
deployed person experiences per year” 
 
 
(c) Sensitivity of PTSD prevalence in military and VA to ±500% change in parameter “Unhealthy recruitment ratio” 
  
(d) Sensitivity of PTSD prevalence in military and VA to ±50% change in parameter “Chance of developing PTSD for non-
combat related reasons” 
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(e) Sensitivity of PTSD prevalence in military and VA to ±50% change in parameter “Quitting treatment ratio in military” 
  
(f) Sensitivity of PTSD prevalence in military and VA to ±50% change in parameter “Quitting treatment ratio in VA” 
  
(g) Sensitivity of PTSD prevalence in military and VA to ±50% change in parameter “Ratio revealing symptoms in military” 
  
(h). Sensitivity of PTSD prevalence in military and VA to ±50% change in parameter “Ratio revealing symptoms for 
veterans” 
Figure A14:  Sensitivity results 
 
In summary, the model outcomes are fairly robust to the changes in all parameters, except 1) 
Average number of traumas a deployed person experiences per year, and 2) Unhealthy 
recruitment ratio. For the first parameter, the implication is that if the remaining military 
personnel in Iraq or other places face with more trauma, e.g., due to escalating situations, there 
will be more PTSD incidence. This is not a surprise. Our model’s prediction is specifically for 2% 
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deployment in the current situation. And for the second parameter, Unhealthy recruitment ratio, 
the analysis presents that if less healthy people are hired, we will see a higher PTSD prevalence. 
This is also not a surprise. Our model runs based on the current status, but we acknowledge that 
if for any reason less healthy/resilient people are hired in the military in the future, PTSD 
prevalence will increase. However, we expect potential changes to influence the prevalence in 
the military by no more than 3 percent point.  
 
Finally, we change all the parameters together to see the effects on the PTSD prevalence. The 
results are reported in Table A5.  
 
 
Table A5: Sensitivity results due to changes in all 8 parameters in Table A4 
 
The results present that the estimation of PTSD prevalence among veterans is reliable. However, 
for the military personnel it can change between 7% and 17% if all important parameters change 
by 50%. We would like to mention that the most sensitive parameters are the average number of 
traumas a deployed person experiences per year (traumas/year/person), and the unhealthy 
recruitment ratio in military. This is not a surprise as if both parameters change (e.g., the 
situation get more escalated in the middle east and we end up hiring less healthy military 
personnel), they may influence PTSD prevalence in the military. 
 
No. Parameters 
Inputs  Outputs 
Comment 
Change in the parameter 
results in… 
Change in 
paramete
rs 
 Change 
in 
military 
PTSD 
Prevalen
ce (Y1) 
Change 
in 
Veteran
s PTSD 
Prevale
nce (Y2) 
1 All 8 parameters in Table 
A4 
±25%  9%-14% 9%-11% ±2.5 percent point change 
in Y1; ±1 percent point 
change in Y2. 
2 All 8 parameters in Table 
A4 
±50%  7%-17% 8%-12% ±5 percent point change 
in Y1; ±2 percent point 
change in Y2. 
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